Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) are a group of chemical compounds with diverse physical and chemical properties. Recent studies have indicated undesired effects of EDCs and PPCPs at their reported trace concentrations (ng l 21 to mg l 21 ). This paper reviews the current knowledge on the sources, properties, occurrence and health impacts of EDCs and PPCPs, and their removal from drinking water using ozonation and ozone/hydrogen peroxide-based advanced oxidation. The paper also examines the potential threats posed by these chemicals to drinking water and public health.
With the advances in analytical capability, the presence of a long list of chemically diverse compounds at trace concentrations has been identified in the environment. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) are almost ubiquitous in municipal sewage treatment plant (STP) effluents and source waters for drinking water treatment plants . Many studies have indicted trace level occurrence of EDCs and PPCPs causing adverse impacts in humans and in ecosystems. There is a perceived risk of indirect contamination via drinking water as studies have shown that conventional treatment systems perform poorly in removing these chemicals from drinking water (Snyder et al. 2003; Westerhoff 2003; Stackelberg et al. 2004) .
Thus the drinking water industry faces a challenge as regulatory bodies and the public become aware of the presence of these compounds in water, which were previously not detectable (Westerhoff 2003) . This paper attempts to provide a summary of the properties of EDCs and PPCPs, their occurrences in the aquatic environment, health impacts, and discusses their removal from water using ozonation and ozone-based advanced oxidation. The paper lists some of the challenges these micro-pollutants present to the drinking water industry. It also discusses the threats EDCs and PPCPs pose to public health, and addresses the current gaps in knowledge and future research needs. It is hoped that this work would encourage readers from various disciplines to get involved and contribute to the ongoing discussion on the presence of EDCs and PPCPs in the aquatic environment.
EDCS AND PPCPS: SOURCES AND PROPERTIES
EDCs are either naturally occurring or synthetic substances that interfere with the functioning of hormone systems resulting in unnatural responses (Birklett 2003) . The United States Environmental Protection Agency (USEPA) defines EDCs as agents that 'interfere with the synthesis, secretion, transport, binding, or elimination of natural hormones in the body that are responsible for maintenance of homeostasis, reproduction, development and/or behaviour' (Birklett 2003) . A number of steroid hormones, both natural and synthetic, alkylphenols, pesticides, organic oxygen compounds, poly aromatic hydrocarbons (PAHs) and dioxins have so far been confirmed as EDCs. Drugs are designed for specific biological action in target receptors (Halling-Sorensen et al. 1998; Jones et al. 2005) . However, they can cause adverse impacts to non-target receptors (Jones et al. 2005; Jasim et al. 2006 ) and some of them (certain oral contraceptive medications, thyroid hormones administered as medications, and estrogen replacement pharmaceuticals) can act as EDCs. To date no exhaustive list of EDCs exists, because, for many chemicals, there is limited and incomplete evidence of endocrine disrupting activity or evidence of endocrine activity which is controversial and also because most chemicals in the market have not been tested for their endocrine toxicity (Snyder et al. 2006a; Kim et al. 2007 ).
The endocrine system controls various basic functions such as reproduction, synchronization of physical development and maintenance in animals and plants with the help of hormones (Lintelmann et al. 2003; Birklett 2003) . Of the various mechanisms by which EDCs affect the hormone system, the principal three (Pocar et al. 2003) are as follows.
They may act as a hormone mimic by binding to the receptor sites of the target cells and activating a response. This is defined as an agonistic effect. In the case of an antagonistic effect, the chemical will act as a hormone blocker and no response is produced as the chemical binds to the receptor and prevents natural hormones from interacting. Figure 1 illustrates these endocrine disruption processes (agonistic and antagonistic effects). Sometimes agonists and antagonists bind to the same receptors resulting in subtle changes in receptor conformation (Birklett 2003) .
EDCs and PPCPs found in the aquatic environment are structurally diverse. Water solubility, adsorption coefficient (log K OC ), bioconcentration (log K OW ) and Henry's law constant (Birklett 2003; Lintelmann et al. 2003 ) are some of the important properties that determine the fate and behaviour of EDCs. A low water solubility and high octanol/water partition coefficient (log K OW ) or high carbon/water coefficient (log K OC ) will promote sedimentation or association with biota (Birklett 2003) . PPCPs are biologically active, not readily biodegradable and often have high water solubility relative to their molecular weight (Jorgensen 2001) . Despite having short half-lives, many PPCPs can still become persistent in the aquatic environment owing to their continual disposal and release in the aquatic environment (Jasim et al. 2006) .
EDCs and PPCPs find their way into watercourses by many routes including direct discharges into water; excretion and inappropriate disposal after use of drugs and chemicals by householders; agricultural and cattle feedlot runoff; industrial and STP effluents; accidental releases (through spills, run off, atmospheric deposition); and release of compounds indirectly through diffuse sources such as storm water runoff (Jones et al. 2004; Sumpter 2005; Falconer et al. 2006) . Moreover pollutants can be transported via watercourses to new areas far from their sources, for example persistent organic pollutants (POPs) can accumulate in areas such as the Arctic where they have never been used or produced (Lintelmann et al. 2003) . Due to strict regulations, point sources such as manufacturing industries of both human and veterinary medicines do not contribute to pharmaceuticals pollution as much as nonpoint sources such as households and agricultural runoff (Jones et al. 2003) . About 33% of the total volume of drugs and 25% of the total sold is disposed of with household waste or in drains in Germany and Austria, respectively (Kummerer 2004 
OCCURRENCES IN THE AQUATIC ENVIRONMENT
Herbicides constitute more than half of all pesticides used in the developed world (Hua et al. 2006a) . A number of studies have reported the occurrence of pesticides and herbicides and their metabolites in surface water, groundwater and near-surface aquifers in the United States (Thurman et al. 1992; Kolpin et al. 1996 Kolpin et al. , 1998a Kolpin et al. ,b, 2000 Kolpin et al. , 2002 Boxall et al. 2004) . Kolpin et al. (1998a) detected pesticides including atrazine, metachlor and prometon, in 54.4% of groundwater samples in 1,034 sites across the United States. However, concentrations of the detected contaminants were generally less than 1 mg l 21 . Atrazine, of which about 3 £ 10 6 kg per year is used in the great lakes basin, has also been frequently detected in river waters in Ontario, Canada (Frank & Logan 1988; Hua et al. 2006a,b; Jasim et al. 2006) . A detailed survey conducted by the United States Geological Survey (USGS) in 139 streams across 30 states in the United States detected 82 of 95 target compounds that included steroids, plasticizers, detergent metabolites, veterinary medicines and other organic water contaminants. Steroids and nonprescription drugs were the most frequently detected contaminants with over 80% occurrence (Kolpin et al. 2002) . Boxall et al. (2004) reported occurrences of metabolites more frequently than their parent compounds. Acetachlor ESA and acetachlor OXA were detected 30% more frequently than their parent compound acetachlor (Boxall et al. 2004) . Similar conclusions were also drawn by Kolpin et al. (1998b) . Degradates often have a much lower K OC value than their parent compounds. Thus those degradates are more likely to be released by STP effluents or be 0.0034 (Lintelmann et al. 2003) 6.20 (Lintelmann et al. 2003) p-p 0 DDE 72-55-9 315.9 (Westerhoff et al. 2005) 0.024 (Lintelmann et al. 2003) 5.76 (Lintelmann et al. 2003) ,0 (Westerhoff et al. 2005) transported to surface and ground waters from the soils.
Metabolites of chemicals are also important;
Persistent and mobile degradates are often difficult to identify and the costs associated with their analysis can be high (Boxall et al. 2004) .
About 100 The foundation also reported frequent occurrences (.65% of samples) of ibuprofen, meprobamate, dilantin and iopromide in finished drinking water. Atrazine occurred at the highest concentrations of any contaminant tested in both raw and finished water but far below the maximum contaminant level of 3 mg l 21 (Khiari 2007) . In Ontario, Canada, ibuprofen was detected in finished drinking water with a median concentration of 0.5 ng l 21 and 13 ng l 21 when the sources of water were lakes and rivers, respectively, which were contaminated with upstream STP effluents (Metcalfe et al. 2004 ). Zuccato et al. (2000) reported the occurrence of the antibiotic tylosin, a veterinary growth promoter, in drinking water at a concentration of 0.6-1.7 ng l 21 .
EDCs such as bisphenol A (BPA), alkylphenols, phthalates and PAHs can leach into drinking water when plastics pipes are used in supply lines. BPA is used for relining drinking water supply lines and as coatings for many fittings. Concentrations of BPA up to 1 mg l 21 have been reported in water supplies. BPA may also leach from lacquer in food cans into water supplies (Gomes & Lester 2003) . PAHs can be remobilized into the drinking water when water mains are coated with coal-tar pitch. Maier et al.
(2000) as cited by Gomes & Lester (2003) noted that disinfection with chlorine might lead to the leaching of PAHs from coal-tar pitch. Prolonged or permanent neurological injuries including cognitive impairment and behaviour abnormalities may occur in children, particularly to the foetus if exposed to dioxins and PCBs (Falconer et al. 2006) . Conventional treatments such as coagulation, sedimentation and filtration have been found to remove less than 25% of most EDCs and PPCPs and are largely ineffective for removing dissolved organic contaminants (Westerhoff 2003; Vieno et al. 2006; Kim et al. 2007 ). Stackelberg et al. (2007) found that clarification process with ferric chloride (FeCl 3 )
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as coagulant accounted for the removal of only 15% of the average concentration of organic contaminants during drinking water production at a US drinking water treatment facility. The removal of diclofenac, ibuprofen, benzafibrate, carbamazepine and sulfamethoxazole by ferric sulphateassisted coagulation in both milliQ water and natural water was studied by Vieno et al. (2006) . All the PPCPs studied showed poor removal (,10%), except diclofenac (66%).
Free chlorine and chloramines can treat a range of EDCs and PPCPs, mainly hydrophilic compounds (Stackelberg et al. 2007; Snyder 2008) . However, free chlorine is much more efficient than chloramines at removing EDCs and PPCPs (Khiari 2007; Snyder 2008) .
Advanced water treatment technologies such as ozonation, granular activated carbon (GAC) adsorption, and ultraviolet (UV) irradiation have shown promise in removing EDCs and PPCPs. For UV treatment, a typical disinfection dose of (5-50 mJ cm 22 ) was found to be several orders of magnitude lower than doses required for the removal of most chemicals (Snyder et al. 2003; Westerhoff 2003; Khiari 2007; Snyder 2008 However, PAC can be very useful in short-term applications such as for removal of pesticides after the first storm following their applications (USEPA 2001) . Reverse osmosis (RO) and nanofiltration have been found to be highly effective in removing EDCs and PPCPs (Snyder et al. 2006a; Snyder 2008) . But they are very costly and a portion of the water is lost as brine. Disposal of brine is a significant problem ) and the finished water has a corrosive nature (Westerhoff 2003) . Thus most drinking water treatment facilities are not likely to install RO (Westerhoff 2003) . Second order reaction rate constants of some organic compounds and pharmaceuticals are listed in Table 3 .
High K O3 values of carbamazepine, dichlofenac, EE2, sulfamethoxazole and roxithromycin indicate that these pharmaceuticals will react with ozone quickly and undergo rapid transformation (Huber et al. 2003 pharmaceuticals (Huber et al. 2003) . Ozone stability in natural water is difficult to assess, as the effect of NOM is variable and unknown. It can act as both an initiator and an inhibitor of ozone decomposition and scientists are yet to be able to estimate the fractions of NOM responsible for promotion or inhibition of ozone decay (Von Gunten 2003). Huber et al. (2003) , however, observed that, regardless of the water matrix, relatively low ozone doses (0.5-2 mg l 21 )
are sufficient for complete transformation of pharmaceuticals with K O3 . 10 5 M 21 S 21 . In the case of AOPs, an initial O 3 concentration similar to the DOC value of the water matrix might ensure availability of sufficient ozone for reaction with H 2 O 2 (Zweiner & Frimmel 2000) . In summary it can be observed that the overall efficiency of AOPs and ozonation would largely depend on the zOH radical scavenging capacity of natural water, NOM content and type, and oxidation reaction kinetics of the targeted chemicals (Zweiner & Frimmel 2000; Huber et al. 2003; Von Gunten 2003) .
The removal of clofibric acid, benzafibrate, carbamazepine, primidone and dichlofenac during drinking water treatment was investigated by Ternes et al. (2002) . While dichlofenac and carbamazepine were almost completely eliminated at an ozone dose of 0.5 mg l 21 , removal of clofibric acid was # 40% even at elevated ozone doses of 2.5-3.0 mg l 21 . Moderate removal for benzafibrate and premidone were observed with 50% removal at ozone doses of 1.5 mg l 21 and 1.0 mg l 21 , respectively, and removals of . 80% at an ozone dose of 3.0 mg l 21 . Another study by Ternes et al. (2003) found X-ray contrast media such as iopromide, iopamidol, diatrizoate, and iomeprol were extremely recalcitrant at an ozone dose of 5 mg l 21 .
Diatrizoate was the most recalcitrant compound showing only 36% removal even at 15 mg l 21 O 3 dose. Nakada et al. (Snyder et al. 2006b ). Also disinfection by zOH radicals is poor compared with O 3 and there is a possibility of forming additional disinfection by-products (Snyder et al. 2006b; Wert et al. 2007) .
To date little is known about the formation, fate, detection and toxicity of oxidation by-products of EDCs and PPCPs (Westerhoff 2003) . Bromate, which does not undergo degradation in biological filters, is the only byproduct of ozonation regulated in drinking water treatment (Von Gunten 2003). Huber et al. (2003) noted that typical ozone doses for removing fast reacting pharmaceuticals would not produce significant amounts of bromate.
Although the target of the ozonation is to degrade the parent compounds to effectively reduce their biological activity, Vieno et al. (2007) noted that recent studies have observed that this goal might not always be achieved.
Quinolone, which is primarily responsible for the pharmacological effect of ciprofloxacin, is not attacked by ozone (Vieno et al. 2007) . Thus by-products of oxidation of EDCs and PPCPs are of concern since they might as well be toxic (Huber et al. 2003; Snyder et al. 2006b; Vieno et al. 2007 ).
CHALLENGES POSED BY EDCS AND PPCPS TO THE DRINKING WATER INDUSTRY
Currently there exist no regulatory guidelines to control the occurrence of EDCs and PPCPs in the environment.
Moreover, a significant portion of the contamination is occurring from non-point sources. With growing public concern at the presence of EDCs and PPCPs in water, the drinking water industry faces a challenge as to which compounds should be treated and to what level they should be treated as maximum contaminant levels are not known (Jasim et al. 2006) .
Extremely low concentrations of these compounds in the environment pose an analytical challenge . Although there have been some recent advances in analytical methods (Westerhoff 2003) , differing polarities and functionalities of various compounds still make it hard to identify them at a concentration range of mg l 21 to ng l 21 .
Moreover, very few laboratories have the necessary facilities to analyse them and costs can be substantial . As these compounds have varying composition and physicochemical properties, their removal requires advanced treatment processes which would need significant capital investment and skilled labour, and the public may not be willing to pay for the extra cost for risks that have not been well established . Furthermore, contamination will vary from region to region and will probably change with time as well, depending upon the use of specific chemicals or medicines. For example clofribric acid, a lipid regulator, is no longer widely used in North America and thus its occurrence in North American waters compared with Europe is sparse (Betts 2002; Boyd et al. 2003) .
Ozonation and ozone-based AOPs have significant potential for removing EDCs and PPCPs from drinking water. Unfortunately, data on the efficiency of ozonation and advanced oxidation processes in removing these contaminants are not conclusive (Betts 2002) . Moreover economically feasible ozone doses will probably form by-products that could also be toxic (Snyder et al. 2006b ).
However, as NOM concentration in natural waters is several magnitudes higher than trace contaminant concentrations, it is probably more prudent to prioritize research on by-product toxicity from NOM rather than those from trace contaminants (Snyder et al. 2006b) . (Webb et al. 2003) . However, one potential concern is the presence of cytotoxic drugs such as anti-neoplastics (e.g. cyclophosphamide), which are carcinogenic, teratogenic and risks may exist at any level of exposure (Webb et al. 2003) . The use of therapeutic doses to estimate the risk thus may not be applicable to genotoxins such as cyclophosphamide (Webb et al. 2003) . Moreover, at present, individual toxicity of a compound is considered while setting up drinking water guidelines, but the synergistic, long-term, low concentration effect of multiple organic compounds present in water is not known (Stackelberg et al. 2004) .
Due to the soaring demand for water and depleting fresh water resources, artificial ground water recharge with STP reclaimed water is being considered in many parts of the world, in arid regions in particular. However, there is increasing concern that groundwater recharge would contaminate groundwater with EDCs and PPCPs (Betts 2002) . Factors such as location of the treatment plant, treatment technologies used at the drinking water treatment facility and the relative degree of contamination of the source water greatly influence the contamination profile and concentration in finished drinking water (Metcalfe et al. 2004 ). Given the current paucity of data and the fact that the contamination from EDCs and PPCPs differs geographically and temporally, it is necessary that further research be directed to detect the level of occurrence of EDCs and PPCPs in raw water, to determine temporal and spatial factors influencing the contamination of raw water and effects of the treatment technologies used in the production of drinking water (Metcalfe et al. 2004) . (Kunisue et al. 2004; Minh et al. 2006) .
EDCS AND PPCPS: IMPLICATIONS FOR GLOBAL ENVIRONMENTAL HEALTH
Concentrations (ng g 21 ) of DDTs found in breast milk in Iran,
China, Turkey and Mexico were 3 -27 times higher than those found in countries such as Japan, Canada, Sweden and Germany (Kunisue et al. 2004) . Often chemicals or drugs that are expired or have been banned from the market or fail to register in the industrialized countries find their way to markets in developing countries (Jamall & Davis 1991; Okeke et al. 1999) . (Ahmed 2000) .
They may be released from body fat during starvation and can also enter infants during pregnancy or through breast milk. This could lead to a bi-directional interaction between the immune system and the endocrine system. EDCs may alter the reproductive system, which in turn may affect the immune system and vice versa (Ahmed 2000) . A significant portion of the population in developing countries is under the stress of malnutrition and infectious diseases. Environmental toxins would interact with malnutrition and infectious disease to magnify their individual impact and, also, the impact on the immune system (Jamal & Davis 1991).
Moreover, lack of a regulatory framework to minimize the exposure to chemicals exacerbates the pollution scenario in those regions of the world (Jamall & Davis 1991) .
Thus people in developing countries are often at higher risk of exposure to toxicants leading to adverse health effects (Craft et al. 2006) .
One particular concern with PPCPs in water is the global rise of antibiotic resistance. Antibiotics may escape the STPs, find their way to the watercourses and increase resistance in natural bacterial populations (Jones et al. 2003) . Tamiflu, the effective antiviral for avian influenza, can escape STPs and even UV radiation cannot substantially degrade it (Fick et al. 2007) . Thus there is a concern that tamiflu and its metabolites (especially oseltamivir carboxylate) may be released into the aquatic environment and lead to increased resistance in the bird-flu virus. Poor quality antibiotics including degraded and expired antibiotics, misuse and overuse of antibiotics by physicians in clinical practice, misuse by the public, improper sales together with crowding and improper sewage disposal contribute to the development of antibacterial resistant strains in developing countries (Okeke et al. 1999) . Also political unrest, abject poverty, mass migration and unhygienic environments with a lack of health care facilities nurture antibiotic resistance in those countries (Kapil 2005) .
This has increased the overall medical costs of communities due to frequent hospitalizations, longer hospital stays and elevated treatment costs. This increase in cost due to bacterial resistance is of greater consequence, notably in the developing countries where the economy is already overburdened. Resistant genes could very well be transported to other areas via watercourses and even through migration of people and tourists.
Industrialized nations, along the pathway of their development, have observed a shift in the epidemiological transition to the suite of chronic illness such as asthma, learning disabilities, congenital malformations and cancers as the leading causes of death (Suk et al. 2003) . It is probably the exposure to synthetic chemicals in the air, water, soil and food chain that are contributing to the changing patterns of paediatric diseases, especially the increasing incidences of chronic diseases in children.
The availability of cheap child labour, the lack of occupational and environmental protection in conjunction with constant export of hazardous chemicals and toxic wastes from industrialized countries to developing countries have placed children in those regions at a twofold risk of infectious diseases and chemical hazards (Suk et al. 2003) .
The health implications of the exposure to toxic chemicals for children is considerably higher compared with adults as their developing systems are more delicate and they might not be able to repair the damage that is triggered by early exposure to toxicants (Suk et al. 2003) .
CONCLUDING REMARKS
The risk of water borne diseases still prevails in many parts of the world. Emerging technologies such as ozonation will probably not be able to totally replace chlorine as a water purifier and disinfectant (Shiru 2000) . Although data on adverse impact of EDCs and PPCPs on humans via drinking water is not conclusive, as a precautionary principle we can say that our drinking water should be free of chemicals that have the potential to cause hormone disruption. Thus further research is warranted to study to the occurrence and elimination of EDCs and PPCPs from drinking water. No single treatment process will be able to remove all contaminants from water and, therefore, multiple treatment systems would probably be required to achieve water treatment goals (Snyder et al. 2006b ). Advanced water treatment technologies will also act as secondary barriers for drinking water contaminants, such as microorganisms, and might as well remove many other unknown chemicals
that are yet to be reported (Betts 2002; Reynolds 2003) .
However, the cost of advanced treatment technologies must be justified before they are implemented.
Due to various socio-economic factors, the risk of exposure to chemicals causing endocrine disruption is significantly higher in developing countries. However, little has been done towards addressing this issue, partly because they are still fighting with other immediate socio-economic and health-related problems. There is also a significant gap in scientific knowledge and awareness regarding the potential adverse impact of EDCs and their handling technologies.
Thus in developing countries often the long-term risks posed by EDCs do not receive appropriate attention from the government and other concerned agencies. But it would not be pragmatic to ignore the long-term risks. Each society perceives and manages risks according to its own values and priorities (Craft et al. 2006) . Therefore, the technologies to handle emerging contaminants such as EDCs and PPCPs will fail if passed to the developing countries without building the capacity to identify and perceive the ill-effects of EDCs.
Research on EDCs should, therefore, be promoted in developing regions as well, and timely and appropriate assistance from developed countries is necessary.
The global nature of many environmental problems is becoming more and more evident. Thus a holistic international approach is necessary to fight the challenges of the emerging pollutants in water. It is indeed necessary to establish concerted international as well as local policies to ensure minimal exposure to EDCs, and also their limited and appropriate usage. Collaborative research should be undertaken to monitor high-risk groups to identify the pathways of exposure and potential adverse impacts.
Appropriate drug disposal practices, manufacturing environmentally friendly chemicals, minimizing the overuse and inappropriate use of pesticides and drugs, and appropriate treatment of STP effluents are some options that could be considered to minimize pollution from EDCs and PPCPs.
Effective communication and translation of the risks of
EDCs and PPCPs in terms of individual regions or cultures, preparing experts in the relevant fields, education and formulation of policies that are compatible with local conditions would probably minimize the global risk.
